Cargando…
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211145/ https://www.ncbi.nlm.nih.gov/pubmed/32388676 http://dx.doi.org/10.1007/s15010-020-01441-4 |
| _version_ | 1783531393944387584 |
|---|---|
| author | Kow, Chia Siang Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7211145 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72111452020-05-11 Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis Kow, Chia Siang Hasan, Syed Shahzad Infection Correspondence Springer Berlin Heidelberg 2020-05-10 2020 /pmc/articles/PMC7211145/ /pubmed/32388676 http://dx.doi.org/10.1007/s15010-020-01441-4 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Kow, Chia Siang Hasan, Syed Shahzad Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title | Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title_full | Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title_fullStr | Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title_full_unstemmed | Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title_short | Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis |
| title_sort | glucocorticoid versus immunoglobulin in the treatment of covid-19-associated fulminant myocarditis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211145/ https://www.ncbi.nlm.nih.gov/pubmed/32388676 http://dx.doi.org/10.1007/s15010-020-01441-4 |
| work_keys_str_mv | AT kowchiasiang glucocorticoidversusimmunoglobulininthetreatmentofcovid19associatedfulminantmyocarditis AT hasansyedshahzad glucocorticoidversusimmunoglobulininthetreatmentofcovid19associatedfulminantmyocarditis |